Company-wide revenue
Reported revenue in 2021 ¥352.25B Reported revenue in 2025 ¥496.83B
- growth amount
- +¥144.58B
- growth annualized
- +9.0%
- growth total
- +41.0%
Japanese company profile · 4151
Kyowa Kirin Co.,Ltd.
In its FY2025 public filing, Kyowa Kirin Co.,Ltd. reports Pharmaceuticals Business. The page shows business-level revenue and profit where the source disclosures support comparison.
Original Japanese company name: 協和キリン株式会社
English company name recorded in Japan's EDINET filer data. English company name source
Reported company-wide figures
- Company revenue
- ¥496.83B ↗ FY2025 · fiscal year ended December 2025
What does this company do?
What does this company do?
Kyowa Kirin Co.,Ltd.'s largest reported business by revenue in FY2025 was Pharmaceuticals Business.
FY2025 · fiscal year ended December 2025 View original filing ↗ The source document may be in Japanese.
Business structure
How does it make money?
| Business | Segment revenue | Revenue share | Segment profit (loss) |
|---|---|---|---|
| Pharmaceuticals Business | ¥496.83B ↗ | 100.0% | — |
All values are in Japanese yen (JPY). No currency conversion is applied. FY2025 · fiscal year ended December 2025. Revenue and profit are shown only where the filing and data support a comparison.
Original Japanese label
- Pharmaceuticals Business
- 医薬事業
- Segment revenue
- セグメント収益
- Segment profit (loss)
- セグメント利益（損失）
Original Japanese label
- Pharmaceuticals Business
- 医薬事業
- Segment revenue
- セグメント収益
- Segment profit (loss)
- セグメント利益（損失）
Reported Segment revenue by business over time
Reported Segment revenue by business over time
| Fiscal year | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Pharmaceuticals Business | ¥352.25B | ¥398.37B | ¥442.23B | ¥495.56B | ¥496.83B |
All amounts are in Japanese yen (JPY). Each figure links to the original Japanese filing. Blank cells indicate no comparable figure was disclosed. Business figures may not add up to consolidated figures.
What is growing?
What is growing?
Business revenue growth
Pharmaceuticals Business
Reported revenue in 2021 ¥352.25B Reported revenue in 2025 ¥496.83B
- growth amount
- +¥144.58B
- growth annualized
- +9.0%
- growth total
- +41.0%
View original filing
This describes a reported period; it is not a forecast.
What has changed?
What has changed?
Not disclosed or not safely comparable in the available filings.
Source
Public filing
FY2025 · fiscal year ended December 2025
The source document may be in Japanese.
Filing ID: S100XPTY
View original filing ↗Ask about this company
Ask about this company
The source document may be in Japanese.